You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The Rehovot, Israel-based firm expects to soon receive marketing clearance from the US Food and Drug Administration for its methylation-based Bladder EpiCheck test.
The Israeli-based startup will use the funds to continue development of its EpiCheck methylation platform and to develop the Lung EpiCheck assay.
Osang previously granted nonexclusive US distribution rights to the PCR-based test to SG Blocks and has a manufacturing arrangement for the test with Nexus Dx.
The companies have agreed to join their respective technologies into an integrated product for artificial intelligence-based prostate cancer diagnosis.
The deal covers Agena's MassArray platform for genetic variant measurement, as well as genetic testing applications and other related products.
A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.
HemoScreen is a portable, point-of-care complete blood count analyzer that uses disposable cartridges that include all necessary reagents.
MeMed believes its tests can be used to identify which COVID-19 patients require more aggressive treatment with corticosteroids.
Phoenix will distribute Sight OLO blood analyzers initially in the United Arab Emirates, followed by the rest of the Gulf Cooperation Council region.
The firm signed a deal with Zotal to be exclusive Israeli distributor of the test, which measures proteins in patient blood to detect diabetic kidney disease.